跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
P-52
首页
药物
P-52
P-52
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Recombinant polypeptides having Ph1 p I epitope antigenicity and methods of diagnosing allergy in vitro
US 7148019 B2
申请人: PHADIA AB
优先权: 2001
US
4 件公开
Block copolymer comprising a vinyllactam block, cosmetic composition and use of this polymer in cosmetics
EP 1514532 A1
申请人: OREAL
优先权: 2003
EP
Whitening cosmetic emulsion containing plant extractives
CN 105078852 A
申请人: GONG CANFENG
优先权: 2015
CN
Methods for diagnosis of Pseudoperonospora cubensis infection and selection of plant resistance genes to the same
US 11560600 B2
申请人: UNIV NORTH CAROLINA STATE
优先权: 2017
US
Tacrolimus ointment composition
CN 108158979 A
申请人: ZHEJIANG REACHALL PHARMACEUTICAL CO LTD
优先权: 2018
CN
Soapberry plant-extracted facial cleansing mousse and preparation method thereof
CN 110882190 A
申请人: JIANGSU BADIEN BIOTECHNOLOGY CO LTD
优先权: 2019
CN
Rhizoma polygonati fructan, pharmaceutical composition and application
CN 116253806 A
申请人: UNIV CHENGDU TRADITIONAL CHINESE MEDICINE
优先权: 2021
CN
Process for producing chlorfenapyr by using proline as acid-binding agent
CN 116589394 A
申请人: KAIFENG BOKAI BIOCHEMICAL CO LTD
优先权: 2023
CN
一种提高透皮吸收率的化妆品制备方法
CN 117838609 B
申请人: 广州熙然化妆品有限公司
优先权: 2024
CN
Traditional Chinese medicine composition formula for treating herpes zoster
CN 119950597 A
申请人: LOU BIWU
优先权: 2025
CN
第 1 / 2 页
上一页
下一页
药物
反馈